THU0527 Lesinurad, A Selective Uric Acid Reabsorption Inhibitor, in Combination with Xanthane Oxidase Inhibitors: SUA and Flares Composite Endpoint from Phase III Studies in Gout Patients (Clear 1, Clear 2 and Crystal)

Puja Khanna(University of Michigan), Robert Morlock, Scott Baumgartner, J. Robinson(Ipswich Hospital), Eskinder Tafesse(AstraZeneca (United States))
Annals of the Rheumatic Diseases
June 1, 2016
Cited by 1


Related Papers